Quest Diagnostics

Quest Diagnostics, a medical laboratory company headquartered in the US, has reported its carbon emissions for recent years. In 2024, their total emissions were approximately 183,197,000 kg CO2e. This figure includes Scope 1 emissions of about 103,102,000 kg CO2e, Scope 2 emissions (market-based) of approximately 72,820,000 kg CO2e, and Scope 3 emissions totalling around 562,475,000 kg CO2e.

For 2023, Quest Diagnostics reported total emissions of approximately 181,439,000 kg CO2e. Their Scope 1 emissions were about 113,925,000 kg CO2e, Scope 2 emissions (market-based) were approximately 77,514,000 kg CO2e, and Scope 3 emissions totalled about 631,003,000 kg CO2e.

The company's climate commitments include a target to reduce its Scope 1 emissions by 30% from 2021 levels by 2030, and a similar commitment to reduce its Scope 2 emissions by 30% from 2021 levels by 2030. These targets are considered near-term and absolute reductions. Quest Diagnostics has disclosed data for Scope 1, 2, and 3 emissions for several years, highlighting their engagement in carbon emissions reporting.